Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Cholangiocarcinoma (CCA) is a lethal bile duct cancer that responds poorly to current standard treatments. A new therapeutic approach is, therefore, urgently needed. Adoptive T cell transfer using chimeric antigen receptor (CAR) T cells is a new therapeutic modality with demonstrated efficacy in hem...

Full description

Bibliographic Details
Main Authors:	Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, Thaweesak Chieochansin, Jatuporn Sujjitjoon, Sopit Wongkham, John Maher, Mutita Junking, Pa-thai Yenchitsomanus
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Oncology
Subjects:	adoptive T cell therapy chimeric antigen receptor integrin αvβ6 immunotherapy cholangiocarcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.657868/full

Similar Items

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
by: Kamonlapat Supimon, et al.
Published: (2021-03-01)

Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma.
by: Thanich Sangsuwannukul, et al.
Published: (2022-01-01)

Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
by: Thanich Sangsuwannukul, et al.
Published: (2022-01-01)

Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
by: Chutamas Thepmalee, et al.
Published: (2018-06-01)

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2022-04-01)

Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
by: Mutita Junking, et al.
Published: (2017-10-01)

Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells
by: Chutamas Thepmalee, et al.
Published: (2020-10-01)

High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients’ samples
by: Ployploen Phikulsod, et al.
Published: (2023-01-01)

Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
by: Piriya Luangwattananun, et al.
Published: (2022-06-01)

Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma
by: Pornpimon Yuti, et al.
Published: (2023-12-01)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by <i>Butea monosperma</i> Agglutinin
by: Karuntarat Teeravirote, et al.
Published: (2021-05-01)

Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-κB)-mediated inflammation in dengue virus infection
by: Mayuri Tarasuk, et al.
Published: (2022-09-01)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
by: Sawanyawisuth Kanlayanee, et al.
Published: (2011-08-01)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
by: Prin Sungwan, et al.
Published: (2021-03-01)

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
by: Doungdean Tummanatsakun, et al.
Published: (2019-08-01)

Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells
by: Chutipa Chiawpanit, et al.
Published: (2022-07-01)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
by: Nathakan Klinhom-on, et al.
Published: (2021-04-01)

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction
by: Jatuporn Sujjitjoon, et al.
Published: (2021-02-01)

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients
by: Paksiree Saranaruk, et al.
Published: (2023-03-01)

Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
by: Paweena Dana, et al.
Published: (2021-12-01)

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
by: Nisa Chuangchot, et al.
Published: (2023-07-01)

Adaptor Protein 1A Facilitates Dengue Virus Replication.
by: Umpa Yasamut, et al.
Published: (2015-01-01)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
by: Suthida Panwong, et al.
Published: (2021-10-01)

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways
by: Piya Prajumwongs, et al.
Published: (2021-01-01)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
by: Kulthida Vaeteewoottacharn, et al.
Published: (2019-05-01)

Piperine suppresses growth and migration of human breast cancer cells through attenuation of Rac1 expression
by: Benjaporn Buranrat, et al.
Published: (2022-01-01)

Novel adiponectin variants identified in type 2 diabetic patients reveal multimerization and secretion defects.
by: Prapaporn Jungtrakoon, et al.
Published: (2011-01-01)

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
by: Kern Rei Chng, et al.
Published: (2016-06-01)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
by: Penkhae Utaijaratrasmi, et al.
Published: (2018-01-01)

Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
by: Shuguang Pan, et al.
Published: (2024-03-01)

Phylogenetic molecular evolution and recombination analysis of complete genome of human parechovirus in Thailand
by: Thaweesak Chieochansin, et al.
Published: (2021-04-01)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
by: Chatchai Phoomak, et al.
Published: (2019-02-01)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
by: Saowaluk Saisomboon, et al.
Published: (2019-05-01)

Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
by: Wunchana Seubwai, et al.
Published: (2014-01-01)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
by: Kulthida Vaeteewoottacharn, et al.
Published: (2019-02-01)

Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
by: Daraporn Chua-on, et al.
Published: (2020-07-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
by: Aussara Panya, et al.
Published: (2023-12-01)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
by: Timo Alexander Auer, et al.
Published: (2023-05-01)

Diagnosis of Cholangiocarcinoma
by: Dong Woo Shin, et al.
Published: (2023-01-01)